Sevelamer Carbonate Powder, For Suspension
Product Images NDC 65862-930
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 65862-930). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2. Change In Serum Phosphorus (mg/dl) From Baseline To Week 2 By Subgroup (Sevelamer Fig1)
Figure 3: Percentage Of Patients (y-axis) Attaining A Phosphorus Reduction From Baseline (mg/dl) At Least As Great As The Value Of The X-axis (Sevelamer Fig2)
Figure 4. Mean Phosphorus Change From Baseline For Patients Who Completed 52 Weeks Of Treatment (Sevelamer Fig3)
Package Label-principal Display Panel (0.8 g Pouch Carton)
Package Label-principal Display Panel (2.4 g Pouch Carton)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.